Objective: Assess the extent to which rebound hypercoagulability-related VTE recurrences occur in the 2 months following discontinuation of OACs. Data sources: Published, randomized controlled ...
Using a large U.S. health care claims database, we found that 1.58% of hospitalized medically ill patients-or about one in every 63 such admissions-develop clinical VTE over 90 days. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback